Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Open Access Articles

The Roles of Alternative Splicing in Tumor-immune Cell Interactions open Access plus

Volume: 20   Issue: 10
Pp: 729-740
Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang
DOI:10.2174/1568009620666200619123725

Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-like Receptor Agonist and Radiation open Access plus

Volume: 20   Issue: 5
Pp: 372-381
Yoshiaki Sato, Hironori Yoshino*, Eichi Tsuruga and Ikuo Kashiwakura
DOI:10.2174/1568009620666200115161717

Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects open Access plus

Volume: 20   Issue: 3
Pp: 168-186
Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Syed Nudrat Nawaid Shah and Muzna Shah
DOI:10.2174/1568009620666191220151856

Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma open Access plus

Volume: 19   Issue: 9
Pp: 698-706
Xiaohua Zhang, Fengbin Gao and Shan Zhong*
DOI:10.2174/1568009619666190206120615

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer open Access plus

Volume: 19   Issue: 1
Pp: 74-80
Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*
DOI:10.2174/1568009618666180709163718

Role of MicroRNAs in Treatment Response in Prostate Cancer open Access plus

Volume: 18   Issue: 10
Pp: 929-944
Anshuli Razdan, Paul de Souza* and Tara Laurine Roberts
DOI:10.2174/1568009618666180315160125

Noxa: Role in Cancer Pathogenesis and Treatment open Access plus

Volume: 18   Issue: 10
Pp: 914-928
Rami Z. Morsi, Rouba Hage-Sleiman, Hadile Kobeissy and Ghassan Dbaibo*
DOI:10.2174/1568009618666180308105048

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open Access plus

Volume: 17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI:10.2174/1568009617666170330120452

Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer open Access plus

Volume: 16   Issue: 4
Pp: 346-356
Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su
DOI:10.2174/1568009616666151207105851

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer open Access plus

Volume: 15   Issue: 8
Pp: 665-683
Otília Menyhart, Libero Santarpia and Balazs Gyorffy
DOI:10.2174/156800961508151001101742